StockNews.com upgraded shares of DexCom (NASDAQ:DXCM – Free Report) from a hold rating to a buy rating in a research note published on Friday. DXCM has been the subject of several other reports. Canaccord Genuity Group upped their target price on shares of DexCom from $144.00 to $145.00 and gave the stock a buy rating […]
Norges Bank bought a new position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) in the 4th quarter, HoldingsChannel.com reports. The institutional investor bought 4,353,112 shares of the medical device company’s stock, valued at approximately $540,178,000. Other institutional investors and hedge funds have also made changes to their positions in the company. Valley National […]
Blood Glucose Monitoring Market Set to Witness Explosive Growth by 2033 briefingwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from briefingwire.com Daily Mail and Mail on Sunday newspapers.
Trexquant Investment LP reduced its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 12.7% in the 4th quarter, HoldingsChannel reports. The firm owned 186,838 shares of the medical device company’s stock after selling 27,116 shares during the period. DexCom accounts for about 0.5% of Trexquant Investment LP’s investment portfolio, making the stock […]
Kentucky Retirement Systems Insurance Trust Fund reduced its stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 6.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 13,765 shares of the medical device company’s stock after selling 973 shares during the period. […]